Accolade Inc. (ACCD) PT Raised to $17 at Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Accolade (ACCD) surges after a beat-and-raise EPS report
June 30, 2023 6:27 AM EDTAccolade (NASDAQ: ACCD) shares advanced almost 13% in premarket Friday trading after the healthcare software firm offered a better-than-expected outlook and delivered solid FQ1 results.
Accolade reported a loss per share of $0.52 on revenue of $93.2 million, beating the analyst consensus that was calling for a loss per share of $0.62 on sales of $90.27M. The adjusted gross margin came in at 43.5%, missing the consensus by 50 basis points.
Our consistently strong financial results reinforce our belief that an advocacy-led care... More
